Accel Research Sites - Birmingham Clinical Research Unit — Birmingham, Alabama

Accel Research Sites - Birmingham Clinical Research Unit is a clinical research site located in Birmingham, Alabama, United States 35216.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Accel Research Sites - Birmingham Clinical Research Unit has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: SARS-CoV-2 Infection, COVID-19, SARS-COV-2 Infection.

Sponsors: BioNTech SE, Eli Lilly and Company, Pfizer.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accel Research Sites - Birmingham Clinical Research Unit?

Accel Research Sites - Birmingham Clinical Research Unit has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accel Research Sites - Birmingham Clinical Research Unit conducted?

Accel Research Sites - Birmingham Clinical Research Unit has 6 clinical trials on record, with 1 currently active. Their work covers SARS-CoV-2 Infection, COVID-19, SARS-COV-2 Infection.

Is Accel Research Sites - Birmingham Clinical Research Unit accredited by Crixeo Health?

Yes — Accel Research Sites - Birmingham Clinical Research Unit holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Accel Research Sites - Birmingham Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.